HSP90 tyrosine phosphorylation induced by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors was reported to increase its association with endothelial nitric oxide (eNOS) [78], a marker for pulmonary hypertension and pulmonary fibrosis [79]. This evidence concerns the gene HSP90AA1 and pulmonary fibrosis.